Will we break £4.00 today ????????? |
There's news coming here, I can smell it |
 Quick counterpoint - think back to last year when the institutions (2 in particular) started selling (basically forced selling under their own fund rules).
2nd August last year 433p and 6 weeks later 244p. OXB said nothing.
By the end of November we were less than 170p and that was following a pretty astounding interims presentation of new work / new customers and IM selling us ABL at cost for shares printed at a huge premium to market price.
QED I wouldn't expect them to say anything about the share price moving up 10% as it's still well below what a smaller company with nothing like our current FY forecast was trading on prior to that August drop.
There are only a few (current) things which we all know well:-
None of the insiders bought after the results which for OXB suggests they couldn't.
When they stopped reporting new work wins they promised to regularly update a KPI table which they haven't.
They have told investors (via the IR email link) that they plan on some kind of quarterly update but haven't.
We know they have a commercial CAR-T deal for myeloma which is most likely to be for Jansen / J&J and if so would be a really big thing for OXB, but we have heard no detail since.
We know we have a signed framework with Serum and that they are lead contractor on the R21 malaria vaccine which is now finally in roll-out, but we don't know if that is what our MSA deal is for. It seems the most likely contender but we just don't know. Again that would be a big thing for OXB.
It could also literally be anything else, not forgetting that the richest listed company in Europe already owns 12% of OXB and has said that they intend to buy up speciality service companies to the pharma industry.
I strongly suspect that the last item there is what Blackrock have latched onto, because it's odds on free money for them in exchange for an unknown wait. |
that is exactly what I have been wondering- if we get into 410-450 territory I would suspect BOD will be under much scrutiny to start updating us all :) |
The BOD clearly have no wish to make any announcements at the present time. However they should now be considering their options if events (e.g. ~10% rise today or evidence of leak) result in formal request for rns. |
Breaking out |
CRISP / CAR-T synergy HTTps://crisprmedicinenews.com/news/crispr-enhances-car-t-cell-cancer-therapies/ |
:)
You know my thoughts on the eventual end of OXB for us as ordinary shareholders - and it isn't via bad news - it's some future point in time with Novo ringing around Serum, BlackRock, Vulpes, etc. and asking what it will cost.
Remember the last 2 business updates with OXB increased the forecast (e.g. 30+ to 35+ percent CAGR over the next 3 years) so it's really unlikely to be shock bad news. Something horrible and they would tell you with an RNS during the day. I have a feeling that the price rise on Friday was because the RNS for tomorrow morning has been signed off and submitted now, but I hope that system is much more secure than I'm hinting at. |
Harry,I'm sure we won't be the only ones checking in at 7am to see if we are going to be put out of our misery. |
Changes of Personnel at board level ? |
BMS chooses Car T over Bispecific in MM |
I would say it's either a coincidence or that they are up to something which some people have twigged.
They don't need money and if it was a fundraising the price would be going the other way.
Takeover brewing is really unlikely as we have some big holders who collectively own more than half.
Malaria is the obvious guess, but that has been hovering for so long now.
The CAR-T news they have already basically told us all but the names and the size.
Something else? |
Harry, is that a usual occurrence in your view :) |
OXB's website down too? |
... within 4 months |
Projections on this breakout are 480 then 600 ( give or take 10) |
Or (slightly more cynically) we are about to find out why none of the insiders could buy after the results but the boys in the market have already heard something. |
Last time the market was very kind here allowing everyone to get in around the time of the results and run with the upslope charting wise - this time they are leading the share price upwards prior to the release of any new information which means the nervous/less decided here will have to keep waiting until much may be baked into the share price Who said share trading was ever fair :)
nai etc |
I will second that Connello.
On the secret level 2 page (click this link then press the "Today" bar in the chart, then scroll to the bottom of the page) I can't remember it looking like that before.
It needs a student of the black arts to explain. |
There was a time circa September/October 2023 where the price continued to move up to 530 without any news. The trend was our friend.
Unfortunately a seller appeared & put an end to that.
Hopefully on this occasion we will have our long awaited news/Update to support the increasing share price |
Active again. 11th month high |
With my glass half full hat it's only a month since the board assured investors at the AGM that it was all on track and going well. I'm sure Frank thinks that's all we need to know - i.e. his full year results presentation was incredibly positive and he's said it's still on target.
However, and as you note, when he previously made the point that we are going away from reporting individual contract wins (as per my example today of the pre-interims period last year), then this running total KPI table was promised in lieu and we have yet to see it - which I still think is an easy win for them which for some reason they are choosing not to do.
Why? Well there are many possibilities and maybe most likely is that they decided 3 months post FY results (29th April) would be the day - which as Phil notes is Monday.
As I type the volume has gone mad and the price is up, so maybe an indication there that a RNS is in the works? |
Register for streaming realtime charts, analysis tools, and prices.
Hot Features
Premium
